Just back from a PhD committee at @uio.no 🎓 Impressive RCT of ~20,000 participants showed: #HEV vaccine safe in adults but should be avoided before and during early pregnancy. And the timing: just a day after the Nobel Prize in Medicine announcement! lnkd.in/eiV97GCb

🗓️ 🕒 Save the date for #ESWI2027: The largest European-based influenza conference returns for its 11th edition in Valencia, 26-29 September 2027. Subscribe to our newsletter to be the first to receive updates: eswi.org/form/newslet...

🍄 #BalkanFungus in 🇷🇴 - landmark meeting for #MedicalMycology I shared an update on #cryptococcus, from screening and early recognition to diagnosis & management. Early diagnosis can make all the difference 💙 Congratulations @efisg-escmid.bsky.social and the amazing Cluj team! @escmid.bsky.social

Chronic liver disease can be destabilised by #influenza and other respiratory infections. Honored that our #ESGVH Chair, Prof. @oana-sandulescu.bsky.social joins the #ESWI Board to connect liver health, vaccination and respiratory prevention. @escmid.bsky.social @eswinfluenza.bsky.social

ESWI@eswinfluenza.bsky.social · 2w ago

The #ESWI #Fluzine is back! 🔔 In September's edition: new Coalition Partner & ESWI Associate Members, ESWI #WOHC2026 session recordings, #IDC update - and more. Read the full newsletter here 👉 mailchi.mp/eswi/fluzine... and subscribe at ESWI.org! #Influenza #EUHealth #PublicHealth

A new #EUCIC #IPC cohort in Ljubljana 💫 Fantastic evolution in a program we were piecing together several years ago. #AMS take-home: Tailor your ab choice. Your AMS plan. To your country. Your setting. Your patient. Evidence travels. Good stewardship adapts. @escmid.bsky.social @eucic.bsky.social

Truly honored to join #ESWI and to be part of such an exceptional group of board members&experts. Looking forward to contributing my expertise and exchanging ideas to advance influenza science and public health. Grateful for the opportunity. Excited for the work ahead. @eswinfluenza.bsky.social

ESWI@eswinfluenza.bsky.social · 2w ago

The #ESWI #Fluzine is back! 🔔 In September's edition: new Coalition Partner & ESWI Associate Members, ESWI #WOHC2026 session recordings, #IDC update - and more. Read the full newsletter here 👉 mailchi.mp/eswi/fluzine... and subscribe at ESWI.org! #Influenza #EUHealth #PublicHealth

Honoured and proud that our Chair, Prof. @oana-sandulescu.bsky.social delivered a fantastic keynote at #ESCV2026 in Porto! “Practical ART decision-making in HIV-HBV coinfection” - a timely reminder that HBV status matters in ART decisions. #HIV #HBV @escvirology.bsky.social @escmid.bsky.social

Friday morning = keynote time at #ESCV2026 in Porto! My keynote: Practical ART decision-making in HIV-HBV coinfection 4 patient trajectories 4 ART decisions 4 things to know The message? HBV matters. Thank you @escvirology.bsky.social 👏👏 @esgvh.bsky.social @escmid.bsky.social

⏰ TIME TO REGISTER! 🌍 Major international experts in viral hepatitis - all in one place. Join ESGVH for 3 days covering hepatitis A–E, emerging viruses & challenging cases. 📅 27–29 Nov 2026 | 💻 Online 👉 Register now lnkd.in/e53ChGBN @escmid.bsky.social

Starting in 3 hours! Join us: HCV Elimination: A Multi-society Perspective on Progress, Gaps and Next Steps 📅 10 September 2026 ⏰ 3 pm CEST 💻 Zoom 🔗 Participation is free. Register here: lnkd.in/e577hvey @aasldnews.bsky.social @idsainfo.bsky.social @inhsu.bsky.social @escmid.bsky.social

A thought to carry into autumn 🍂 At #ESC2026, I was invited to discuss the cardioprotective role of high-dose flu vaccination for the elderly. A great example of ID&cardio shared responsibility for the same patient. Flu prevention is also CV prevention 💉❤️ @escardio.bsky.social @medscape.com

Breakthroughs in #ViralHepatitis begin with shared commitment. Read below an excellent paper published in #Germs_MDPI by our valued #ESGVH EC leaders: Prof @oana-sandulescu.bsky.social, Prof M Maticic, Assoc Prof I Hasanoglu. 👉 brnw.ch/21x4vKJ @escmid.bsky.social #WorldHepatitisDay

No one should die from a disease that is preventable, diagnosable and treatable. Yet around 5M people in Europe live with chronic hepatitis B or C, and almost 60,000 people die each year from liver disease linked to these infections. More information about the situation: bit.ly/WorldHepDay2026

World Hepatitis Day 2026: Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach

While Europe has made steady progress in preventing hepatitis B and C the region is set to miss the 2030 target to eliminate viral hepatitis as a public health threat.

bit.ly

But gaps remain: ➡️ Hepatitis B vaccination coverage uneven across the EU/EEA ➡️ access to harm reduction services for people who inject drugs remains inadequate in many countries. Annual epidemiological report on Hepatitis B: www.ecdc.europa.eu/en/publicati... #Hepatitis #HepatitisB #HepatitisC

Hepatitis B - Annual Epidemiological Report for 2024

For 2024, 30 EU/EEA countries reported 37 605 cases of hepatitis B virus (HBV) infection, corresponding to a crude rate of 7.5 cases per 100 000 population.

ecdc.europa.eu

Effective solutions to control viral hepatitis already exist, including vaccination, harm reduction, testing and treatment. This #WorldHepatitisDay, the challenge is ensuring these life-saving interventions are accessible to everyone who needs them. bit.ly/WorldHepDay2026 #IDsky #EpiSky

#MaPaCi2026, Tg Mures Multidisciplinary care begins by seeing the person beyond the diagnosis. For people living with viral hepatitis or HIV, trust and reducing stigma are essential parts of care. Medicine is strongest when knowledge, compassion, and collaboration come together. #WEEPIFoundation

Amazing event, fantastic colleagues, insightful discussions! 👏👏

ESGVH (ESCMID Study Group for Viral Hepatitis)@esgvh.bsky.social · 4mo ago

#ID are major challenges in pregnancy, with potential consequences across generations. As co-organizer of the @escmid.bsky.social course Two Lives at Risk, @esgvh.bsky.social proudly spotlights #ViralHepatitis in pregnancy: maternal-fetal health&transmission prevention. @oana-sandulescu.bsky.social

One week left to register for the @escmid.bsky.social course: "Navigating infectious diseases in pregnancy", proudly supported by @esgvh.bsky.social. Keynote lectures from distinguished experts: @oana-sandulescu.bsky.social, Gülşen Özkaya Şahin, Heli Harvala. Register at the link: lnkd.in/dadZHyBA

REVERSE joined the ID & HIV Dialogues conference in 🇷🇴! We presented our latest findings on: ✅ Reducing MDR bacterial infections through collaboration. ✅ Implementing stewardship frameworks that work. ✅ New evidence for managing carbapenem-resistant Gram-negatives. Discover REVERSE bit.ly/3Q8BgrZ

An incredible 2 days at HIV Advanced Training Forum, Bucharest! Energy, interaction & case-based learning to advance HIV care. Inspired by our trainees & the high demand for this program. Thanks to our outstanding faculty & our sponsors Gilead Sciences and ViiV Healthcare.

#ESGVH is proud to organize the #HIV Advanced Training Forum 2026 in Bucharest, led by Prof. @oana-sandulescu.bsky.social & Assoc. Prof. Juan Ambrosioni. A 2-day course empowering early-career clinicians with practical, evidence-based HIV care. @eacsociety.bsky.social @escmid.bsky.social

Oana Sandulescu@oana-sandulescu.bsky.social · 7mo ago

HIV experts from 🇷🇴, 🇳🇱, 🇪🇸, 🇩🇪, 🇬🇧, 🇵🇱 gather in RO for the HIV Advanced Training Forum. International program for young clinicians, endorsed by leading ID organizations. Proud to share knowledge, connect and support the next generation shaping HIV care. @eacsociety.bsky.social @escmid.bsky.social

HIV experts from 🇷🇴, 🇳🇱, 🇪🇸, 🇩🇪, 🇬🇧, 🇵🇱 gather in RO for the HIV Advanced Training Forum. International program for young clinicians, endorsed by leading ID organizations. Proud to share knowledge, connect and support the next generation shaping HIV care. @eacsociety.bsky.social @escmid.bsky.social

Starting now! Still time to join us: us06web.zoom.us/webinar/regi... @escmid.bsky.social @esgvh.bsky.social #UCHID

Welcome! You are invited to join a webinar: A Collaborative session between ESGVH & UCHID: Treatment for All in HBV: Pros & Cons. After registering, you will receive a confirmation email about joining...

Session Schedule: Welcome message by the head of both groups (10 m) First speaker: Prof: Gamal Esmat Cairo University, Egypt Treatment for All in HBV: Pros & Cons (20 m) Second speaker: Prof. Oana San...

us06web.zoom.us

ESGVH (ESCMID Study Group for Viral Hepatitis)@esgvh.bsky.social · 7mo ago

Our collaborative webinar @esgvh.bsky.social and #UCHID is starting now! Our Chair, Prof @oana-sandulescu.bsky.social will talk about Rethinking priorities for viral hepatitis management. Today at 11.00 CET! Registration is free: us06web.zoom.us/webinar/regi... @escmid.bsky.social

For 3 days, 🇷🇴 Romania was an international hub for #IPC training, part of the #EUCIC certificate Participants from 10 countries came together: 🇬🇧 🇩🇪 🇮🇹 🇪🇸 🇸🇮 🇧🇦 🇲🇹 🇹🇷 🇰🇷 🇷🇼 to explore how molecular&bioinformatics tools support surveillance and improve patient safety @escmid.bsky.social @eucic.bsky.social

Delighted to partner with #UCHID for this impactful webinar on Treatment for all in HBV. #ESGVH is represented by our Chair, Prof @oana-sandulescu.bsky.social, and EC members Prof Nabil, Assoc Prof Hasanoglu. 📅 March 5, 11 PM CET 🔗 Register: us06web.zoom.us/webinar/regi... @escmid.bsky.social

📢 Ecraid Foundation Science Meeting: registration deadline extended! Join industry leaders, researchers, clinicians & policy experts to discuss cutting-edge science & collaboration in infectious diseases and clinical research. Accredited by NVMM (11 points) and ABIC www.eventbrite.nl/e/ecraid-fou...

Ecraid Foundation Science Meeting

Engage with Europe’s first dedicated clinical research network for infectious diseases, meet ID experts and foster collaboration.

eventbrite.nl

📢 Join us for a #HepDelta webinar by world class speakers: #ESGVH 🤝 #SOLDA Hepatitis Delta: Challenges in Diagnosis & Management 💻 Online, today ⏰ 11 a.m. CET 🔗 Register for free: lnkd.in/g5AXFGdv #WebSymposium #ViralHepatitis @esgvh.bsky.social @escmid.bsky.social @oana-sandulescu.bsky.social

#ESGVH message for #HepTestWeek 25: Testing saves lives. Awareness drives change. Action moves us forward. 🩺 Early diagnosis = timely treatment 🤝 Normalize testing, reduce stigma 🌍 Elimination is possible if we act now @escmid.bsky.social @worldhepalliance.bsky.social @oana-sandulescu.bsky.social

🌍 Delighted to speak at #ESWI2025 in Valencia on how #infection can decompensate, unmask, or trigger #NCDs — a vital link we see daily in practice. 💡 Time to act: Let's prevent NCDs by preventing infections. #InfectiousDiseases #IDC #PublicHealth #Influenza #Prevention @eswinfluenza.bsky.social

🌍 Proud of #ESGVH Chair Prof @oana-sandulescu.bsky.social for her inspiring role at #EACS2025 in Paris! 🎓🎤 Now Vice Chair of #YING, she’s advancing education & building bridges 🌉 between #ESCMID 🦠 and #EACS 🧬 for a healthier, more connected future 🌐💫 @escmid.bsky.social @eacsociety.bsky.social